{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-006335","form_type":"8-K","ticker":"BVS","cik":"0001665988","company_name":"Bioventus Inc.","filed_at":"2023-03-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.067944+00:00","generated_at":"2026-06-18T13:12:41.245035+00:00","sec_items":["2.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Bioventus deconsolidates CartiHeal after settlement, records $88.5M loss on disposal","bullets":["Transferred CartiHeal shares to trustee and paid $10M to former securityholders under settlement agreement.","Deconsolidation effective Feb 27, 2023; CartiHeal treated as discontinued operation with $88.5M loss on disposal.","Pro forma net loss for nine months ended Oct 1, 2022 increases to $134.3M from $126.8M historical.","Settlement resolves non-payment of $50M milestone triggered Feb 13, 2023; company avoids litigation.","Bioventus retains no ownership or voting rights in CartiHeal during interim period."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-006335","json":"https://secwatch.observer/filing/0001628280-23-006335.json","markdown":"https://secwatch.observer/filing/0001628280-23-006335.md","text":"https://secwatch.observer/filing/0001628280-23-006335.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1665988/000162828023006335/0001628280-23-006335-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1665988/000162828023006335/bvs-20230227.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T13:12:41.245035+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}